The largest pan-European medical service provider specialising in diagnostics imaging and cancer care services.
Operator of diagnostic imaging and cancer care centres in Europe
Centres across 14 European countries at exit
We supported Euromedic’s management team by driving a holistic value creation plan.
During this period, the company grew both organically as well as through market consolidation and multiple greenfield investments expanding its centre base by 100 facilities to 144 sites in total at the time of our exit. This was coupled with a comprehensive strategic and operational programme which involved, among other things, expansion into cancer care, streamlining of operations and disposal of non-core divisions as well as multiple optimisation initiatives.
In August 2014 we sold our stake to Ares Life Sciences.